C12N 2795/18141
Use of virus, viral particle or viral elements as a vector
C12N2795/18141 (Use of virus, viral particle or viral elements as a vector) appears on 18 US grants and 29 published applications in this corpus.
Search patents in C12N- Granted patents
- 18
- Published applications
- 29
- Assignees
- 17
- Inventors
- 54
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 3 |
| 2015 | 1 | 0 |
| 2016 | 2 | 3 |
| 2017 | 1 | 1 |
| 2018 | 1 | 2 |
| 2019 | 3 | 2 |
| 2020 | 0 | 1 |
| 2021 | 1 | 4 |
| 2022 | 1 | 2 |
| 2023 | 1 | 0 |
| 2024 | 2 | 2 |
| 2025 | 1 | 4 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2795/18142Virus or viral particle as vehicleIndexing code10
- C12N 2795/18143Viral genome or elements thereof as genetic vectorIndexing code4
- C12N 2795/18144Chimeric viral vector comprising heterologous viral elements for production of another viralIndexing code0
- C12N 2795/18145Special targeting system for viral vectorsIndexing code0
Recent patents
- Methods and compositions for microbial delivery of double stranded RNA28 Jul 2026US 12,690,596 B2Rnaissance AG LLC
- Compositions and methods for tumor immunotherapy11 Mar 2025US 12,246,031 B2Checkmate Pharmaceuticals, Inc.
- Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (ASC) and methods of use10 Dec 2024US 12,162,916 B2UNM Rainforest Innovations
- Packaging oligonucleotides into virus-like particles10 Sep 2024US 12,084,655 B2Checkmate Pharmaceuticals, Inc.
- Compositions comprising a PCSK9 peptide conjugated to a qbeta carrier and methods of using the same11 Jul 2023US 11,696,941 B2The USA, as represented by the Secretary, Dept. of Health and Human Services
- Methods and compositions for microbial delivery of double stranded rna8 Oct 2026US 2026/0305618 A1Rnaissance AG LLC
- Sialokinin immunogen and methods for using same13 Aug 2026US 2026/0234184 A1
- Vaccine composition for novel coronavirus infection28 Aug 2025US 2025/0269009 A1Institute of Biophysics, Chinese Academy of Sciences
- Compositions and methods for tumor immunotherapy14 Aug 2025US 2025/0255898 A1Checkmate Pharmaceuticals, Inc.
- Compositions targeting apoptosis-associated speck-like protein with caspase activation and recruitment domain (asc) and methods of use6 Feb 2025US 2025/0042962 A1UNM Rainforest Innovations
Most cited
By later US patents
- Method of preparing polypeptides in cell-free translation system38US 5,478,730 AInstitute of Protein Research · 1995
- RNA bacteriophage-based delivery system32US 6,159,728 ABTG International Limited · 2000
- T cell receptor display4US 8,741,814 B2Adaptimmune Limited · 2014
- T cell receptor display4US 9,279,122 B2Adaptimmune Limited · 2016
- PCSK9 peptide vaccine conjugated to a Qbeta carrier and methods of using the same2US 10,279,019 B2Stc. Unm · 2019